NCT00003430View on ClinicalTrials.gov

L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

April 30, 2000

Study Completion Date

April 30, 2000

Conditions
Head and Neck CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

L-778,123

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003430 - L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors | Biotech Hunter | Biotech Hunter